Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3591_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
29.08.2026
Размер:
89 Мб
Скачать
11 Neurointerventions Including Aneurysm Interventions
109
Table 11.3 Endovascular aneurysm treatment techniques
1. Endosaccular lling a. Simple coiling b. Balloon-assisted coiling c. Stent-assisted coiling d. Combined balloon and stent-assisted coiling
2. Flow diversion and vessel wall healing a. Parent artery occlusion b. Stent graft c. Flow diverter
3. Combined/hybrid a. Intra-aneurysmal ow disruptors
11.3.8 Endovascular Techniques
Historically, endovascular treatment of aneurysms has evolved along two lines: (i) lling the aneurysmal lumen with embolic materials for which detachable coils have evolved as the most suitable ones; and (ii) diverting the ow away from the aneurysm thereby promoting aneurysmal thrombosis and healing of the neck. Endovascular aneurysm treatment techniques are summarized in Table11.3.
11.3.9 General Technical Guidelines
• Access: The most common access used is a transfemoral or transradial access with a 8F/6F puncture. The choice between transfemoral and transradial access depends on the patient’s anatomy, the procedure being performed, the requirement of a coaxial or triaxial system, and the prefer­ences of the operator.
• Approach/tortuosity: In patients with tortuous anatomy, it is very crucial to have a stable positioning of the guide catheter. The triaxial system with most possible distal placement of the guide catheter (up to cavernous ICA) provides enhanced support and stability.
• Antiaggregation [11]: Any procedure which requires an intracranial stent will incite an inammatory response with platelet activation and clot formation. To prevent this, adequate antiplatelet priming at least for 3–5days is to be done. The optimal dose and treatment regimen var­ies from operator to operator. The most commonly used regimen is aspirin (150mg/day) and clopidogrel (75mg/ day) orally. Other drugs available in the market are prasu­grel and ticagrelor. In emergent situations, the loading dose of aspirin + clopidogrel (300mg each) or the infu­sion of abciximab or tiroban infusion is advocated.
• Aneurysm morphology: Saccular aneurysms are classi­ed into narrow and wide-necked aneurysms. Narrow neck aneurysms (<4mm) are more favorable for endosac­cular lling. Wide neck/bifurcation aneurysms often require scaffold/assistance to contain the coils within the
aneurysmal sac. For minimally wide-necked aneurysms (4–7 mm), balloon assistance (i.e., inated across the neck) would sufce; while very wide neck aneurysms require the assistance of a stent or a ow diversion tech­nique. The fusiform/dissecting aneurysms require ow diversion and vessel wall repair techniques to heal.
11.3.10 Simple Coiling
• The discovery of detachable coils by Gugilemi revolu­tionized the aneurysm management. Simple coiling is particularly suitable for narrow neck aneurysms (neck<4 mm) and remains a widely used treatment method at many centers.
• The procedure begins with proling the aneurysm and its neck in an appropriate position followed by safe place­ment of microcatheter inside the aneurysm.
• Shaping of the microcatheter tip is important, and the same is dictated, in a given case, by the aneurysm mor­phology, location, and parent artery curvatures. For instance, S shape is preferred to cannulate superior hypophyseal artery aneurysm.
• After microcatheter placement, the aneurysm is lled pro­gressively by tiny platinum coils. The rst coil is the framing coil (3D coil), the largest possible one, chosen based on the aneurysm dimensions measured followed by lling coils and nishing coils, which are usually soft 2D coils (Fig.11.1).
• There are various types of coils available, including bare coils, coated coils, and bioactive coils. Bare coils are sim­ple platinum coils. Bioactive coils have a coating of thrombogenic materials (like nitinol, hydrogel, or polyglycolic- polylactic acid) over the coils.
• The complications encountered during the procedure include aneurysmal rupture and coil extrusion, coil pro­lapse, and coil stretching.
11.3.11 Balloon-Assisted Coiling
• The advent of balloon microcatheters helped extend coil­ing to relatively wide necked (4–7mm) aneurysms, espe­cially in acute SAH settings (Fig.11.2).
• Balloon microcatheters are either double lumen or single lumen and are compliant or extra compliant to conform with the parent vessel/aneurysmal neck.
• The balloon is inated across the neck of the aneurysm during coiling to prevent coil prolapse.
• Dilute contrast (usually 50%) is used to inate the bal­loon. Utmost attention is required during the balloon preparation as per the vendor guidelines for ensuring
110
L. J. D. Sebastian and N. G. Reddy
Fig. 11.1 Simple coiling in ruptured PCOM aneurysm In A, sentinel hematoma in right parasellar location with SAH extensively in basal cisterns In B, lobulated right PCOM aneurysm is noted In C, after the stable position of the microcatheter, progressive coiling is done In D, check run shows complete packing with obliteration of the aneurysm
a
c
b
d
good visibility, avoiding mixture of gas bubbles and to prevent overination during the procedure.
• The ination time of the balloon is to be kept to minimum to prevent ischemia and thromboembolic complications. (ideally <3min).
• Inated balloon can also serve as a temporary tamponade in case of intraprocedural aneurysmal rupture.
11.3.12 Stent-Assisted Coiling
• Stent-assisted coiling is useful in the treatment of wide­necked aneurysms (Fig.11.3).
• The stent is placed in the parent artery such that it strad­dles the neck of the aneurysm, creating a scaffold that supports and retains the coils within the aneurysm. It also helps promote neointimal growth and ow diversion (to some extent).
• Stents are classied as open- and closed-cell stents based on cell shape. They are divided into laser cut and braided stents based on make. They are either fully or partially retrievable.
• Antiaggregation priming is needed for a minimum of 3days in elective procedures, and loading dose is admin­istered in emergency situations. There is also a need for long-term dual antiplatelet therapy to prevent stent thrombosis.
11 Neurointerventions Including Aneurysm Interventions
111
a
d
b
e
c
f
Fig. 11.2 Balloon assisted coiling in ruptured terminal ICA aneurysm In A, a large aneurysm is seen in the left suprasellar location with SAH and IVH In B and C, lateral and AP proling shows large aneurysm with a pseudolobule
• The delivery microcatheter sizing is different for different stents and makes. The coiling catheter is either jailed or placed through the struts of the stent. Pre-planning includes appropriate sizing of the stent and determining the landing zones.
• Complications include foreshortening of the stent and poor apposition with the parent wall.
In D, after the stable position of microcatheter, coiling is begun In E, a 4×20mm balloon protective device was placed from ICA to M2 MCA In F, nal check run showing near complete obliteration of the aneurysm
11.3.13 Flow Diverter/Braided Stents
• Braided stents are closed cell stents, which are used both in stent-assisted coiling and as standalone procedures. Flow diverters are braided stents with higher metal den­sity and smaller individual cell sizes and shapes (Fig.11.4).
112
L. J. D. Sebastian and N. G. Reddy
Fig. 11.3 Solitaire assisted coiling in a cavernous ICA aneurysm In A, lateral view, a paraclinoidal aneurysm is noted In B, after jailing the microcath­eter in the aneurysm, solitaire (4×30mm) stent is deployed from terminal ICA to cavernous ICA In C, progressive coiling through the microcatheter was achieved In D, nal check run showing obliteration of the aneurysm
a
c
b
d
• The introduction of ow diverters has shifted the focus from aneurysm lling/occlusion to promoting vessel wall healing in the management of aneurysms. The mecha­nism of action is by altering the wall shear stress and cre­ating a scaffold for endothelial cell growth.
tional to its porosity. Porosity is the fraction of metal-free area per total stent surface area. Pore density is the num­ber of pores per unit area. Low porosity offers greater ow reduction into the aneurysm with better ow diver­sion; however, it limits the exibility of the device.
• Pre-planning involves decision-making and proper posi­tioning with good landing zones (avoiding the perforator branches) and good apposition to prevent endoleak and thrombus formation.
• As there is high metal density, antiplatelet priming is of utmost importance to prevent stent thrombosis.
11.3.14 Stent Graft
• Stent grafts are balloon-mounted covered stents, which offer cost-effective solutions in large extradural aneu­rysms (Fig.11.5).
• However, their intracranial use is off label due to their stiff, rigid nature, and covered nature; Hence, it is used mainly in the straight segments such as the arteries of the neck. They are not used in intradural arteries as they have multiple delicate tiny perforators.
• They provide reinforcement and sealing of weakened ves­sel walls with complete exclusion of the aneurysm.
• Complications include less conformability in tortuous arterial segments with few long-term follow-up cases showing asymptomatic vessel occlusion.
11 Neurointerventions Including Aneurysm Interventions
113
Fig. 11.4 Flow diverter in a large cavernous ICA aneurysm In A and B, a large aneurysm from the petro-cavernous ICA is noted In C, deployment of the FD is seen In D, check run shows decreased lling with stasis in the aneurysm
a
c
b
d
11.3.15 Parent Artery Occlusion
• Parent artery occlusion (PAO) or feeder artery occlusion (FAO) is a technique where the artery supplying blood to the aneurysm is intentionally occluded—either for seal­ing the aneurysm or to create a ow reversal/diversion. Reversal of the direction of blood ow in the parent arte­rial segment that harbors the aneurysm promotes healing of the neck and shrinking of the aneurysm. Coils/detach­able balloons are used to occlude the artery (Fig.11.6).
• Patency of the circle of Willis should be assessed before planning PAO. Similarly, the site of origin and size of various important branches in the feeder artery and any variant anatomy thereupon are to be borne in mind. Hence, pre-planning includes balloon occlusion tests for checking the adequacy of collateral ow and other aspects explained above. The site of PAO should be carefully selected such that adequate ow reversal is ensured.
• PAO proves very useful in the treatment of large/giant dis­secting aneurysms of the posterior circulation, which are otherwise very difcult to treat.
• PAO may also be considered for giant dissecting aneu­rysms of ICA as a last resort.
11.3.16 Endosaccular Devices
• Endosaccular ow disruptors create intra-aneurysmal ow disruption and remodeling at the aneurysm-parent artery interface. The entire device is deployed in the aneu­rysm and disrupts blood ow entering and exiting the aneurysm. The mesh across the neck can act as a scaffold for neoendothelial growth. Bifurcations aneurysms like MCA bifurcation and basilar top aneurysms are more suitable for their use.
• Presently available devices are WEB, Contour, LUNA, and Medina devices.
114
L. J. D. Sebastian and N. G. Reddy
a
e
Fig. 11.5 Stent graft placement for the treatment of giant dissecting aneurysm at right lacero-cavernous ICA In A, giant dissecting aneurysm at right lacero- cavernous ICA In B, the guiding catheter was placed distal to the aneurysm In C, stent-graft was placed
b
f
c
g
In D, native image showing kinking in mid-segment In E, good cross ow is noted from the contralateral ICA In F, the balloon is expanded In H, a follow-up scan shows complete exclusion of the aneurysm
d
h
• WEB: Woven endobridge is an endosaccular nitinol braided cage used in wide-necked bifurcation aneurysms. WEB sizing is based on the maximal diameter of the aneurysm.
• Medina: It is a self-expanding mesh containing multiple leaets (petals) that help with ow diversion. It is a hybrid system combining the design of a detachable coil and endosaccular ow disruptor.
• LUNA: It is a self-expanding, mechanically detachable, ovoid ow disruptor.
• Contour: This device has a cup-like conguration and conforms to the shape of the lower half of the aneurysm and the aneurysm neck. Sizing is based on the maximum diameter of the aneurysm.
• While ow disruptors offer advantages in terms of their targeted approach, and a reduced need for long-term anti­platelets, a limitation is their high cost.
11 Neurointerventions Including Aneurysm Interventions
115
a
e
b
f
c
g
d
h
Fig. 11.6 Parent artery occlusion of RVA for treating the dissecting aneurysm from proximal basilar and terminal left vertebral arteries involving left PICA origin In A and B, dissecting aneurysm is noted from proximal basilar and terminal left vertebral arteries involving left PICA origin In C, the right prominent PCOM is noted. Left vertebral artery is hypo­plastic (not shown) In D, a detachable balloon is inated in distal right V3 segment In E, right ICA run, post-occlusion of RVA by detachable balloons, reveals lling of basilar artery through PCOM
11.4 Management ofSubarachnoid Hemorrhage
Aneurysmal Subarachnoid hemorrhage (SAH) is a life­threatening emergency. Understanding its pathophysiology, complications and management is a must for any neurointerventionist.
11.4.1 Pathophysiology
Aneurysm rupture is a complex pathophysiologic event. Following aneurysmal SAH, there is sudden increase in intracranial pressure (ICP), reduced cerebral blood ow
In F, native image shows an inated balloons occluding V2–V3 segment In G, follow-up DSA after 3months shows occlusion of the right verte­bral artery In H, right ICA run reveals lling of basilar artery with no opacication of aneurysm. Patient was asymptomatic at 3 month follow up (Note: detachable gold ball balloons were cost- effective alternatives to coils and were used in high-ow stulas like CCF and in PAO.How ever they are no more available in India)
(CBF), decreased tissue oxygen supply, and impaired cere­bral autoregulation. Systemic abnormalities such as decreased total systemic blood volume, hyponatremia, acti­vation of the coagulation and brinolytic system, and cardio­pulmonary dysfunction also ensue.
11.4.2 SAH-Evaluation andImmediate Management
Sudden severe headache, often described “thunderbolt head­ache” or “headache of life,” is highly suggestive of SAH.Headache can be followed immediately by vomiting, various extent of focal neurological decits, altered senso-
116
L. J. D. Sebastian and N. G. Reddy
Table 11.4 Modied Fischer’s grading in SAH
Category Criteria Grade 0 No SAH or IVH Grade I Minimal/thin SAH (<1mm in thickness) with no IVH Grade II Minimal/thin SAH (<1mm in thickness) with IVH Grade III Dense/thick SAH (>1mm in thickness) with no IVH Grade IV Dense/thick SAH (>1mm in thickness) with IVH or
associated with ICH
rium, and loss of consciousness. In some patients, the symp­toms can be milder or different, e.g., acute onset third nerve palsy.
Whenever SAH is suspected, non-contrast head CT (NCCT) is the imaging modality of choice for conrming the diagnosis and grading its severity. Modied Fisher grade (Table11.4) is widely used for grading of SAH on NCCT as it has high prognostic value; higher grades are associated with subsequent complications of SAH, especially vaso­spasm. Different clinical scoring systems are also available to stratify these patients at presentation. World Federation of Neurological Surgeons (WFNS) and Hunt and Hess scale are popular ones [12, 13].
Acute SAH patients must be clinically stabilized, and basic life support should be ensured and ABC approach (air­way, breathing, circulation) applies in this regard. Some of the other aspects of acute management before securing the aneurysm are listed as follows:
1. Fluid management: Large bore IV line/ preferably central
line is needed to maintain euvolemia.
2. Patients are generally kept nil orally till the culprit aneu-
rysm is secured.
3. Hydrocephalus: CSF diversion is generally preferred
after securing aneurysm. However, hydrocephalus with rapid deterioration may warrant immediate procedures like EVD.
4. BP management: High BP can precipitate aneurysm rup-
ture, while hypotension can compromise cerebral perfu­sion. Hence, maintaining BP in higher-normal range is preferred before securing an aneurysm.
5. Prophylaxis for cerebral vasospasm using calcium chan-
nel blockers (e.g., Nimodipine) is generally administered. However, blood pressure should be maintained in optimal range as described above.
6. Anticonvulsants: Any seizure event can precipitate aneu-
rysm rupture. Hence, prophylactic anticonvulsants are instituted in SAH patients, even though no denite evi­dence exists for this practice [14].
After initial stabilization, the next immediate goal should be denite management of the aneurysm, which can either be surgical (clipping) or endovascular. The next section deals with the management of immediate and delayed complica­tions that may ensue.
11.4.3 Management ofComplications
Endovascular (or surgical) treatment of aneurysm is just one, though essential, component of SAH management, as these patients are prone to a variety of complications, the extent and severity of which depend on the initial grade. Nevertheless, these complications and the ability to treat them or otherwise decide the nal outcome of the SAH management.
Cerebral Vasospasm It is one of the most dreaded com­plications of SAH, which occurs between 4 and 14days of ictus, peaking at 7days. The diagnosis is by the combina­tion of clinical and imaging ndings. Any unexplained clinical deterioration, especially in the period mentioned above, should raise the suspicion of cerebral vasospasm. CT or MRI may show multifocal or sometimes territorial developing infarcts. Perfusion studies (CTP/ASL) will demonstrate areas of decreased cerebral perfusion. Angiographically visible cerebral arterial narrowing may or may not accompany these changes. There are many dif­ferent treatment regimens proposed in the literature for the management of SAH related vasospasm. We describe one of the common protocols which is also followed in our institution:
1. Prophylactic calcium channel blockers, e.g., intravenous nimodipine is started in all patients on admission.
2. Oral nimodipine is proven to be effective [15]. Hence, it is imperative to change to oral nimodipine as early as pos­sible after aneurysm treatment. It can also be adminis­tered through a nasogastric tube.
3. In patients not responding to the above, intravenous mil­rinone can be started.
4. After securing the aneurysm, blood pressure should be elevated so as to raise the cerebral perfusion. Intravenous nor=adrenaline infusion may be started to maintain high B.P.
5. Adequate hydration should be maintained. Central venous pressure monitoring is useful to maintain euvolemia.
6. Intra-arterial nimodipine is given in patients deteriorating in spite of the above treatment. Frequent intra-arterial administration—daily or every 12h—may be required in some patients [16]. In some centers, the femoral sheath is left in situ for a few days.
7. Magnesium sulfate and papaverine are some of the alter­nate drugs useful in vasospasm. Superior cervical gan­glion block is also used in some centers.
8. Use of balloon angioplasty and stents is reserved for symptomatic patients with recalcitrant vasospasm [17].
Delayed Cerebral Ischemia
spasm although microcirculation thrombosis is implicated.
This is closely related to vaso-
11 Neurointerventions Including Aneurysm Interventions
117
Apart from vasospasm treatment, IV heparin or low molecu­lar weight heparin or aspirin are believed to improve cerebral ischemia [18, 19].
Hydrocephalus Patients should be closely monitored for
increase in hydrocephalus. CSF diversion in the form of EVD or VP shunt may be needed.
Hyponatremia Regular monitoring of electrolytes is part of the routine management of SAH.Hyponatremia is very common in the rst 2weeks. Syndrome of inappro­priate secretion of antidiuretic hormone (SIADH) and cerebral salt wasting are important causes [20]. Urinary sodium and osmolality will help in the differential diag­nosis of these conditions and institution of appropriate treatment.
Hypokalemia Patients with potassium level less than
3meq% may need either oral or IV replenishment.
Infections Prophylaxis Routine broad-spectrum antibiot­ics are started in patients needing ventilatory support and those with multiple in-dwelling catheters.
Ventilation Care/Early Tracheostomy Patients requiring
prolonged ventilatory support should be monitored for ventilator associated pneumonia (VAP). It is better to go for an early tracheostomy.
Miscellaneous If the patient is expected to be bedridden for
more than 7 days, DVT prophylaxis should be started. Appropriate bedding and proper nursing care are essential to prevent bed sores. Oral hygiene should be maintained.
Physiotherapy and Rehabilitation Patients discharged with residual decits should be guided for appropriate phys­iotherapy and rehabilitation programs.
11.5 Follow-Up andMonitoring
All patients who have undergone an endovascular proce­dure are advised to undergo check angiogram after 3–6months to conrm the aneurysm occlusion. Aneurysm can regrow secondary to coil compaction, extension of arte­rial dissection, or de novo new aneurysm formation. Larger aneurysm recurrences require repeat treatment, whereas small neck compactions can be followed up with serial imaging. Follow-up angiogram are also important in down­stepping antiplatelet agent once aneurysm/parent artery has healed.

References

1. Surgical Neuroangiography - Vol.2: Clinical and Endovascular Treatment Aspects in Adults | Alejandro Berenstein | Springer [Internet]. [Cited 2021 Jan 19]. Available from: https://www.
springer.com/gp/book/9783540416685.
2. Vlak MH, Algra A, Brandenburg R, Rinkel GJ. Prevalence of unruptured intracranial aneurysms, with emphasis on sex, age, comorbidity, country, and time period: a systematic review and meta-analysis. Lancet Neurol. 2011;10(7):626–36.
3. Wills S, Ronkainen A, Van Der Voet M, et al. Familial intra­cranial aneurysms: an analysis of 346 multiplex Finnish fami­lies. Stroke. 2003;34(6):1370–4. https://doi.org/10.1161/01.
STR.0000072822.35605.8B.
4. Smith RR, Zubkov YN, Tarassoli Y.Pathology and classication of cerebral aneurysms. In: Cerebral aneurysms. NewYork: Springer;
1994. p.10–22. https://doi.org/10.1007/978- 1- 4613- 9532- 4_2.
5. van Gijn J, Kerr RS, Rinkel GJE. Subarachnoid haemorrhage. Lancet Lond Engl. 2007;369(9558):306–18.
6. Frisby J. Brain stem compression by a giant vertebrobasi­lar aneurysm mimicking seronegative myasthenia. J Neurol Neurosurg Psychiatry. 2001;71(1):125–6. https://doi.org/10.1136/
jnnp.71.1.125.
7. Epileptic seizure in intracranial aneurysm - PubMed [Internet]. [cited 2020 Oct 8]. Available from: https://pubmed.ncbi.nlm.nih.
gov/7381354/.
8. Samaniego EA, Roa JA, Hasan D.Vessel wall imaging in intra­cranial aneurysms. J NeuroIntervent Surg. 2019;11(11):1105–12.
https://doi.org/10.1136/neurintsurg- 2019- 014938.
9. Yang ZL, Ni QQ, Schoepf UJ, et al. Small intracranial aneu­rysms: diagnostic accuracy of CT angiography. Radiology. 2017;285(3):941–52. https://doi.org/10.1148/radiol.2017162290.
10. Howard BM, Hu R, Barrow JW, Barrow DL.Comprehensive review of imaging of intracranial aneurysms and angiographically nega­tive subarachnoid hemorrhage. Neurosurg Focus. 2019;47(6):E20.
https://doi.org/10.3171/2019.9.FOCUS19653.
11. Ospel JM, Brouwer P, Dorn F, et al. Antiplatelet Management for Stent-Assisted Coiling and Flow Diversion of ruptured intra­cranial aneurysms: a DELPHI consensus statement. AJNR Am J Neuroradiol. 2020;41(10):1856–62. https://doi.org/10.3174/ajnr.
A6814.
12. Report of world Federation of Neurological Surgeons Committee on a universal subarachnoid hemorrhage grading scale. J Neurosurg. 1988;68(6):985. https://doi.org/10.3171/jns.1988.68.6.0985.
13. Hunt WE, Hess RM. Surgical risk as related to time of inter­vention in the repair of intracranial aneurysms. J Neurosurg. 1968;28(1):14–20. https://doi.org/10.3171/jns.1968.28.1.0014.
14. Rhoney DH, Tipps LB, Murry KR, Basham MC, Michael DB, Coplin WM. Anticonvulsant prophylaxis and timing of sei­zures after aneurysmal subarachnoid hemorrhage. Neurology. 2000;55(2):258–65.
15. Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarach­noid haemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298(6674):636–42.
16. Venkatraman A, Khawaja AM, Gupta S, etal. Intra-arterial vaso­dilators for vasospasm following aneurysmal subarachnoid hem­orrhage: a meta-analysis. J Neurointerv Surg. 2018;10(4):380–7.
https://doi.org/10.1136/neurintsurg- 2017- 013128.
17. Bhogal P, Loh Y, Brouwer P, Andersson T, Söderman M.Treatment of cerebral vasospasm with self-expandable retrievable stents: proof of concept. J Neurointerv Surg. 2017;9(1):52–9. https://doi.
org/10.1136/neurintsurg- 2016- 012546.
118
L. J. D. Sebastian and N. G. Reddy
18. McMahon CJ, Hopkins S, Vail A, etal. Inammation as a predic­tor for delayed cerebral ischemia after aneurysmal subarachnoid haemorrhage. J Neurointerv Surg. 2013;5(6):512–7. https://doi.
org/10.1136/neurintsurg- 2012- 010386.
19. Vossen LV, Weiss M, Albanna W, etal. Intra-arterial nimodipine for the treatment of refractory delayed cerebral ischemia after aneurys-
mal subarachnoid hemorrhage. J Neurointerv Surg. 2023;15:jnis­2023- 021151. https://doi.org/10.1136/jnis- 2023- 021151.
20. Crowley RW, Dumont AS.Hyponatremia and cerebral vasospasm following subarachnoid hemorrhage. Neurol India. 2006;54(3):247.